Status: Recruiting
Compassionate Use of Domperidone for Refractory Gastroparesis
The purpose of this program is to allow the use of domperidone in children from 12 to 21 years of age with symptoms related to motility disorders and Gastroesophageal reflux disease (GERD) who have failed all the standard treatments for their condition.
Participants needed: 20
Trial details
Age: 12-21Biological sex: AllType: InterventionalSponsor: Jose CocjinUpdated: Mar 24, 2026Locations: 1
Eligibility criteria
Male or female [+9]
History of, or current, arrhythmias including ventricular tachycardia, ventricul... [+6]